Lazris David, Gaur Dhruv, Curseen Kimberly, Kavalieratos Dio, Maxwell Meredith, Quest Tammie, Zarrabi Ali John
Emory University School of Medicine, Atlanta, Georgia, USA.
Brown University, Providence, Rhode Island, USA.
J Palliat Med. 2022 May;25(5):802-806. doi: 10.1089/jpm.2021.0577. Epub 2022 Mar 18.
Our academic ambulatory palliative care program has counseled, monitored, and certified patients for cannabis as part of routine palliative care practice for six years. We describe the population certified for cannabis and policies, procedures, and medicolegal challenges in our palliative care clinic. We performed a retrospective review of patients, qualifying diagnoses for cannabis certification, reasons for referral, and number of annual certifications. Between 2015 and 2021, we certified 1711 patients for cannabis. The most common indications were cancer (64%), pain (24%), and neuropathy (9%). Other three months in 2021, 28% of new referrals to our practice were certified for cannabis and 15% of patients were referred explicitly for cannabis certification. Despite legal and practical challenges to implementing a medical cannabis program, our palliative care program has fully integrated cannabis as part of our standard outpatient clinical practice.
我们的学术性门诊姑息治疗项目在常规姑息治疗实践中,已为患者提供大麻咨询、监测并开具证明达六年之久。我们描述了在姑息治疗诊所中获得大麻开具证明的人群以及相关政策、程序和法医学挑战。我们对患者、大麻开具证明的合格诊断、转诊原因和年度开具证明数量进行了回顾性审查。2015年至2021年期间,我们为1711名患者开具了大麻证明。最常见的适应症是癌症(64%)、疼痛(24%)和神经病变(9%)。在2021年的其他三个月里,新转诊至我们诊所的患者中有28%获得了大麻开具证明,15%的患者是明确转诊以获得大麻开具证明的。尽管实施医用大麻项目存在法律和实际挑战,但我们的姑息治疗项目已将大麻完全纳入我们的标准门诊临床实践。